These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 16639329)

  • 1. Duration of in vivo antimicrobial activity of antibiotic-impregnated cerebrospinal fluid catheters.
    Pattavilakom A; Kotasnas D; Korman TM; Xenos C; Danks A
    Neurosurgery; 2006 May; 58(5):930-5; discussion 930-5. PubMed ID: 16639329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction in shunt infection using antibiotic impregnated CSF shunt catheters: an Australian prospective study.
    Pattavilakom A; Xenos C; Bradfield O; Danks RA
    J Clin Neurosci; 2007 Jun; 14(6):526-31. PubMed ID: 17430776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of antibiotic-impregnated shunt catheters in decreasing the incidence of shunt infection in the treatment of hydrocephalus.
    Sciubba DM; Stuart RM; McGirt MJ; Woodworth GF; Samdani A; Carson B; Jallo GI
    J Neurosurg; 2005 Aug; 103(2 Suppl):131-6. PubMed ID: 16370278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do antibiotic-impregnated shunts in hydrocephalus therapy reduce the risk of infection? An observational study in 258 patients.
    Ritz R; Roser F; Morgalla M; Dietz K; Tatagiba M; Will BE
    BMC Infect Dis; 2007 May; 7():38. PubMed ID: 17488498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the efficacies of antibiotic-impregnated and silver-impregnated ventricular catheters on the prevention of infections. An in vitro laboratory study.
    Secer HI; Kural C; Kaplan M; Kilic A; Duz B; Gonul E; Izci Y
    Pediatr Neurosurg; 2008; 44(6):444-7. PubMed ID: 19018152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection rate with application of an antibiotic-impregnated catheter for shunt implantation in children - a retrospective analysis.
    Eymann R; Steudel WI; Kiefer M
    Klin Padiatr; 2009; 221(2):69-73. PubMed ID: 19263325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in external ventricular drain infection rate. Impact of a minimal handling protocol and antibiotic-impregnated catheters.
    Rivero-Garvía M; Márquez-Rivas J; Jiménez-Mejías ME; Neth O; Rueda-Torres AB
    Acta Neurochir (Wien); 2011 Mar; 153(3):647-51. PubMed ID: 21170556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and economic consequences of antibiotic-impregnated cerebrospinal fluid shunt catheters.
    Eymann R; Chehab S; Strowitzki M; Steudel WI; Kiefer M
    J Neurosurg Pediatr; 2008 Jun; 1(6):444-50. PubMed ID: 18518694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effectiveness of antibiotic-impregnated shunt catheters in the treatment of adult and pediatric hydrocephalus: analysis of 12,589 consecutive cases from 287 US hospital systems.
    Parker SL; McGirt MJ; Murphy JA; Megerian JT; Stout M; Engelhart L
    J Neurosurg; 2015 Feb; 122(2):443-8. PubMed ID: 25415066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospital costs associated with shunt infections in patients receiving antibiotic-impregnated shunt catheters versus standard shunt catheters.
    Attenello FJ; Garces-Ambrossi GL; Zaidi HA; Sciubba DM; Jallo GI
    Neurosurgery; 2010 Feb; 66(2):284-9; discussion 289. PubMed ID: 20087127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conservative management of patients with cerebrospinal fluid shunt infections.
    Brown EM; Edwards RJ; Pople IK
    Neurosurgery; 2006 Apr; 58(4):657-65; discussion 657-65. PubMed ID: 16575329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydromer-coated catheters to prevent shunt infection?
    Bayston R; Bhundia C; Ashraf W
    J Neurosurg; 2005 Mar; 102(2 Suppl):207-12. PubMed ID: 16156231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial experience with antibiotic-impregnated silicone catheters for shunting of cerebrospinal fluid in children.
    Aryan HE; Meltzer HS; Park MS; Bennett RL; Jandial R; Levy ML
    Childs Nerv Syst; 2005 Jan; 21(1):56-61. PubMed ID: 15480705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial-impregnated and -coated shunt catheters for prevention of infections in patients with hydrocephalus: a systematic review and meta-analysis.
    Konstantelias AA; Vardakas KZ; Polyzos KA; Tansarli GS; Falagas ME
    J Neurosurg; 2015 May; 122(5):1096-112. PubMed ID: 25768831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of rifampicin and clindamycin impregnated devices against Staphylococcus spp. infection after cerebrospinal fluid diversion procedures.
    Gutiérrez-González R; Boto GR; Fernández-Pérez C; del Prado N
    BMC Neurol; 2010 Oct; 10():93. PubMed ID: 20939914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of complicated shunt infections: a clinical report.
    James HE; Bradley JS
    J Neurosurg Pediatr; 2008 Mar; 1(3):223-8. PubMed ID: 18352767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial suture wound closure for cerebrospinal fluid shunt surgery: a prospective, double-blinded, randomized controlled trial.
    Rozzelle CJ; Leonardo J; Li V
    J Neurosurg Pediatr; 2008 Aug; 2(2):111-7. PubMed ID: 18671615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rifampin-impregnated silicone catheters: a potential tool for prevention and treatment of CSF shunt infections.
    Hampl JA; Weitzel A; Bonk C; Kohnen W; Roesner D; Jansen B
    Infection; 2003 Mar; 31(2):109-11. PubMed ID: 12682816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of cerebrospinal fluid shunt infections in children using systemic and intraventricular antibiotic therapy in combination with externalization of the ventricular catheter: efficacy in 34 consecutively treated infections.
    Arnell K; Enblad P; Wester T; Sjölin J
    J Neurosurg; 2007 Sep; 107(3 Suppl):213-9. PubMed ID: 17918527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infection of cerebrospinal fluid shunts: causative pathogens, clinical features, and outcomes.
    Wang KW; Chang WN; Shih TY; Huang CR; Tsai NW; Chang CS; Chuang YC; Liliang PC; Su TM; Rau CS; Tsai YD; Cheng BC; Hung PL; Chang CJ; Lu CH
    Jpn J Infect Dis; 2004 Apr; 57(2):44-8. PubMed ID: 15118207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.